The mutation was found in two Canadian families that had several members diagnosed with a rapidly progressive type of MS, in which a person’s symptoms steadily worsen and for which there is no effective treatment.
For media enquiries or to connect with researchers in the MacVicar Lab at the Djavad Mowafaghian Centre for Brain Health, please contact Emily Wight, Communications Manager.
- Email: firstname.lastname@example.org
- Phone: 604-417-0165
For general enquiries about MacVicar Lab activities, please contact Katherine Rhodes at email@example.com.
For patients with Parkinson disease (PD), cognitive decline can be one of the most debilitating symptoms of the condition. As many as 80 per cent of people with PD experience some form of cognitive impairment, with up to a quarter of patients presenting symptoms of memory loss or impairment at diagnosis.
Bacteria in the guts of children who had recently developed multiple sclerosis (MS) differed from healthy control children, finds new research from Dr. Helen Tremlett and her University of California research colleagues, including co-PI Dr. Emmanuelle Waubant. These differences were suggestive of a pro-inflammatory environment within the gut bacterial community of the children with MS.
"In Dr. Haas’ lab, we identified the involvement of the transcription factor MEF2 in regulating metaplasticity by accident. The finding was totally unexpected," says Dr. Simon Chen, who completed his PhD in Dr. Kurt Haas’ lab at UBC. Dr.
As 12,000 neurologists descend on Vancouver for the American Academy of Neurology’s 68th annual meeting this week, the Djavad Mowafaghian Centre for Brain Health is poised to make the most of the opportunity to showcase our clinical and scientific leadership in the field.
Three Centre members will be giving talks at plenary sessions the world’s largest gathering of neurologists, taking place at the Vancouver Convention Centre April 15-21:
On April 13, 2016, the World Bank and the World Health Organization will co-host their first-ever high-level meeting on mental health and economic prosperity in Washington, DC. According to the World Bank, the meeting “aims to move mental health from the margins to the mainstream of the global development agenda” and will bring together finance ministers, inter-governmental organizations, and business, academic, and civic leaders to promote critical investments in mental health around the globe.
The UBC Hospital Clinic for Alzheimer Disease and Related Disorders (UBCH CARD) announced this week that Dr. Haakon Nygaard has been appointed to the role of Medical Manager of the clinic. Located within the Djavad Mowafaghian Center for Brain Health at the UBC Hospital, the clinic was under the leadership of Dr. Howard Feldman until his departure from UBC in March.
A protein that was once thought to be involved in only hereditary cases of amyotrophic lateral sclerosis (ALS) evidently misfolds in all cases of ALS, finds new research from Dr. Neil Cashman’s laboratory.
If most of what we know about multiple sclerosis (MS) patients comes from patients who access MS- clinics, how much do we really know about MS patients? New research from Kyla McKay and Dr. Elaine Kingwell, part of the Pharmacoepidemiology in Multiple Sclerosis (PiMS) research team led by Dr. Helen Tremlett, evaluated population-level data on new cases of MS between 1996 and 2004.
With the help of the National Multiple Sclerosis Society, Dr. Alex Rauscher is finding ways to use magnetic resonance imaging (MRI) to measure injury to the brain caused by multiple sclerosis (MS) and, by extension, to quantify how prescribed therapies can prevent or slow damage.